144510.KQ
GC Cell Corporation
KOE · Healthcare · Biotechnology · KR
KRW 14,760.00
+7.74%Margins
Gross margin
16.4%
EBITDA margin
-4.3%
EBIT margin
-6.7%
Net margin
-143.4%
FCF margin
3.3%
-125.2%
Return on equity
-69.3%
Return on assets
-3.7%
Return on invested capital
0.49x
Asset turnover
KRW 7.9B
Cash from operations
KRW 88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026